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COVID-19 pandemic has been a global health emergency due to its association with severe pneumonia and high rate of 
mortality. In the current study, we reported the direct evidence for the variable level of severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) virus infection on several types of oral epithelial cells isolated from the aspirated 
oropharyngeal and bronchoalveolar secretions of severely infected and intubated patients using cytology, confocal based 
immunofluorescence imaging (IF), scanning electron microscope (SEM) and transmission electron microscopic (TEM) 
studies. Cytological analysis showed the presence of keratinised and non-keratinised oral epithelial cells with viral inclusion 
bodies in stratum granulosum and intermedium cells. IF imaging using SARS-CoV-2 spike protein specific antibody 
confirmed the presence of virus inside the stratum spinosum/granulosum (keratinised) and stratum intermedium/superficial 
cells (non-keratinised). No SARS-CoV-2 viruses were seen in stratum corneum cells. SEM analysis also confirms the 
absence of virus like structure on stratum corneum surface while viruses like structure were seen on the stratum 
spinosum/granulosum/stratum/intermedium and stratum superficial cells. This advanced microscopic study confirms directly 
that the virus tends to infect and multiply in the metabolically active or sub-basal cells of oral epithelium and absent in the 
inactive keratinised stratum corneum from shedding zones of oral mucosa.  
Keywords: COVID-19 pandemic, Immunofluorescence, Scanning electron microscope (SEM), Stratum granulosum, 
Stratum intermedium, Stratum spinosum, Transmission electron microscopic (TEM) 
The ongoing 2020 pandemic COVID-19 is caused by 
the severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2). It has been a global health 
emergency due to its high level of infectivity and its 
association with severe pneumonia and high 
mortality. SARS-CoV-2 virus may also replicated  
in the epithelial cells of oropharyngeal region1. 
Primarily, oral symptoms such as taste loss, dry 
mouth and mucosal blistering occur in the majority of 
COVID-19 patients. Surprisingly, very little is 
reported about the infectivity of different cells of oral 
mucosa by SARS-CoV-2 virus2. This virus enters in 
the cells when its spike protein interacts with the 
angiotensin-converting enzyme 2 (ACE-2) receptors 
on epithelial cells3. It was already confirmed by  
in situ hybridization, western blotting, immunohisto-
chemistry and RT-PCR that the oral and nasal cavity 
are the main entry point for this pathogen due to 
overexpression of ACE-2 receptors on epithelial 
cells4. Many reports have confirmed the presence of 
ACE-2 (a host receptor of SARS-CoV-2 binding), 
TMPRSS2 and furin (host proteases to cleave the 
spike protein to release the spike fusion peptide that 
facilitates host cell entry) on the oral mucosal 
epithelium that elicits the internalization of SARS-
CoV-2 virus to cause the infection5, 6. However, the 
expression levels of these receptors and protease are 
entirely variable in the different oral anatomical 
regions as well as the different cellular layers of the 
same regions. Zhong et al., reported that there is a 
significantly higher expression level of ACE-2 protein 
in the lip, tongue and oral mucosa, especially towards 
the basal and sub-basal layer of epithelial cells7. The 
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corresponding gingiva and palate epithelial cells 
showed weak positive ACE-2 staining7. All these 
reports speculated indirectly that the ACE-2, 
TMPRSS-2 and furin positive oral epithelium may 
provide the favourable condition of SARS-CoV-2 
infection8. However, there are negligible reports  
to provide the direct proof of level of infection  
of SARS-CoV-2 in the different keratinized or  
non-keratinised oral mucosal cells. In this study, we 
aimed to provide the direct proof for the presence and 
level of infection of SARS-CoV-2 virus in the different 
cells of oral cavity collected from the oropharyngeal and 
bronchoalveolar secretion of severely infected and 
intubated COVID-19 patient. These were reported 
through pap staining (cytology), confocal based 
immunofluorescence imaging, scanning electron 
microscope and transmission electron microscope. 
 Material and Methods 
 Material Karnovsky`s fixative (0.5% Glutaraldehyde + 2.0 % 
Paraformaldehyde), hematoxylin, eosin, orange G., 
Scott’s water, xylene, DPX, PBS, Poly-L-lysin, epoxy 
embedding kit and DAPI were purchased from Sigma 
chemical company USA. BSA, ethanol was from 
Himedia and Triton X-100 was purchased from Fisher 
Scientific. Osmium tetroxide was procured from Ted 
Pella, and uranyl acetate from Taab, and lead citrate 
from Ladd. Polyclonal anti-SARS-CoV-2 specific 
primary antibody (Abcam; Cat no. ab275759), Alexa 
fluor-594 conjugated anti-rabbit secondary antibody 
(Abcam; Cat no. ab150080), 40 nm gold nanoparticles 
conjugated goat anti- rabbit antibody (Taab) were 
procures and used mentioned along with them. 
 
Methods 
 Ethics statement  Experimental procedures for collecting the 
bronchoalveolar secretion from the severe SARS-
CoV-2 infected (COVID-19 positive) and intubated 
patients from Intensive Care Unit (ICU) were 
performed after written informed consent from all 
participants or patients’ representatives and after 
ethical approval by the Institutional Ethics Committee 
(IEC) of the All India Institute of Medical Sciences 
New Delhi, India (Ref. No. IEC-307/27.04.2020,  
RP-10/202). 
 Sample collection and primary fixation The aspirated oropharyngeal and bronchoalveolar 
secretions containing unstimulated suctioned  
saliva were collected from intubated SARS-CoV-2 
positive patients at COVID-19 Intensive Care Unit 
(ICU), Trauma Centre, All India Institute of  
Medical Sciences, New Delhi between 4th to 6th days 
of admission. These samples were collected in  
freshly prepared Karnovsky`s solution (final 0.5% 
Glutaraldehyde +2.0 % Formaldehyde). The 
oropharyngeal and bronchoalveolar secretions  
(15-20 mL) from the intubated patient were collected 
in a 50 mL falcon containing 20 mL of 2X fixative 
(1% Glutaraldehyde and 4% Formaldehyde in 0.2 M 
PB). The collected sample vials were surface 
sterilized and stored in a specific refrigerator at 4C 
after two hours of incubation at room temperature. 
Available medical records were reviewed before the 
collection of the samples, for information regarding 
demographics, symptom history, underlying 
conditions, infectious disease testing, imaging study 
findings, treatment and advanced supportive care 
received. This investigation was reviewed in 
accordance with the institute ethics for subjects’ 
review procedures. 
 Sample processing for the cellular enrichment The collected bronchoalveolar secretion in 
Karnovsky`s solution was diluted 10 times with 0.1 M 
NaCl solution and strained through 100 µM pore size 
nylon mesh cell strainer. The filtrate was centrifuged 
at 2500 rpm for 3 min in a swinging bucket rotor. The 
cellular pellets were washed 2-3 times for 10 min with 
PBS solution to remove the excess mucus. The 
cellular constituents were enriched by centrifugation 
at 1200 g for 3 min and resuspended again in the 
primary fixative A (0.5% Glutaraldehyde 2.0% 
paraformaldehyde in 0.1M PB buffer) which were 
further used for Pap staining, immunofluorescence, 
SEM, and TEM imaging. 
 Cytological examination/Pap staining of the samples Pre-treated poly L-lysine coated glass slides were 
cyto-spun (700 rpm for 5 min) with 200 µL of 
enriched squamous cells sample to form a smear on 
the slide. This smear was fixed with 90% ethanol. 
After the fixation, the slides were washed under 
running tap water for 1 min. Haematoxylin staining 
was done for 2-4 min and washed (for 1 min each) 
sequentially by running tap water, Scott’s water and 
again with tap water. This smear was dehydrated 
gradually with 70%, 95%, 100% ethanol for 1 min 
each. Alcohol dehydration with 100% ethanol was 
repeated twice. The smear on the slides were treated 
with Orange G for 4 min and again dehydrated with 




ethanol series up to 95%. Slides were dip in Eosin 
stain for 10 min and again treated with 95% ethanol 
and 100% acetone twice. The stained slides were 
treated with xylene three times (5 min each) to clean 
the additional stain and mounted using DPX. 
 
Immunofluorescence using SARS-CoV-2 spike protein specific 
antibody Enriched squamous epithelial cells from the 
bronchoalveolar secretion were rinsed three times 
with 0.1 M phosphate buffer. Samples (10 µL) were 
smeared on poly-L-lysine coated glass slides, and air 
dried at 37°C overnight to fix it. Slide smear was 
permeabilized using PBST (0.1% Triton X-100 in 1X 
phosphate buffer saline) and blocked with 2% BSA in 
PBS for 30 min. Primary antibody (Abcam ab275759, 
polyclonal against S1 spike protein) at 1:500 dilution 
was spread on the slides at room temperature for 4 h 
in a humid chamber and washed with PBS. 
Fluorophore conjugated secondary antibody (Alexa 
fluor-594 conjugated anti-rabbit secondary antibody 
in 1:500 dilution; Abcam, Cat No.- 150080) were 
incubated for 1 h at RT in dark and washed 
thoroughly by phosphate buffer. For nuclear 
recognition, DAPI staining (1 μg/mL) was done for  
5 min and washed with PBS to remove the excess 
amount. Coverslips were mounted in slides using 90% 
glycerol as mounting medium. Fluorescence imaging 
was analysed on a laser confocal microscope (Leica 
SP8 Germany) using different objectives.  
 
Scanning Electron Microscopy For scanning electron microscopy (SEM), the 
enriched and primary fixed cellular component of 
bronchoalveolar secretion were osmicated, dehydrated 
with ethanol, critical point dried (K850, EMS) and 
mounted on double- sided tape on aluminium stub. 
These stubs were sputter coated with a gold-based 
sputter coater (Agar sputter coater) for 180 seconds. 
Electron micrographs were obtained on EVO18 
(Zeiss, Germany) SEM operated at 20 kV accelerating 
voltage, between 8-10 mm average working distance 
with SE detector, and magnifications ranging from 
×5000 to ×30000.  
 
Transmission Electron Microscopy To prepare the specimens for TEM imaging, 
enriched cellular constituents of bronchoalveolar 
secretion collected from the ICU wards of AIIMS, 
New Delhi were further primary fixed if required 
using primary fixative (2.5% Glutaraldehyde+ 2.0% 
paraformaldehyde in 0.1M PB buffer). The primary 
fixed cellular pellets were washed with 0.1 M 
phosphate buffer (pH 7.4) and post-fixed with 1% 
osmium tetroxide in 0.1 M phosphate buffer (pH 7.4) 
for 1 h (secondary fixation) at 4°C. Pellets were again 
washed with distilled water and en-bloc staining was 
done with 2% uranyl acetate for 2 h. These samples 
were again washed with distilled water and 
dehydrated in an ethanol series (30%, 50%, 70%, 
80%, 90%, and 100%). Dehydrated pellets were 
infiltrated with toluene/resin and finally embedded  
in epoxy resin. The blocks were polymerised by 
incubating at 65°C for 48 h. Resin blocks were 
trimmed, polished and 70 nm thin sections were 
sectioned using UC7 ultramicrotome (Leica), and 
mounted on TEM grids. These ultrathin sections were 
stained with 5% uranyl acetate and 5% lead citrate. 
Sections were imaged using Transmission Electron 
Microscopy (Thermo Fisher Scientific Talos F200) 
using a FEG filament operated at 200 kV.  
 Results 
 Sample Collection  The oropharyn geal and bronchoalveolar secretion 
(total 35 samples) from the collection tube of 
intubated severe COVID-19 patients were collected 
between 4th to 6th days of their ICU admission at 
AIIMS New Delhi in Karnovsky`s solution. The 
collection tubes were surface sterilized using the 70% 
alcohols for the decontamination and also to be used 
in the BSL-2 condition. The collected secretion 
contains the oral mucosal cells along with the 
bronchoalveolar cells. The oral mucosal cells were 
enriched by straining with the help of appropriate size 
cell strainer (nylon mesh filter). These enriched oral 
epithelial cells were used for various microscopic 
studies to explore the type of cells and the level of the 
SARS-CoV-2 infection.  
 Papanicolaou (Pap) imaging of bronchoalveolar secretion 
from COVID-19 infected intubated patients showed viral 
specific inclusion bodiesin oral epithelium The oropharyngeal and bronchoalveolar secretion contains numerous oral epithelial cells that were stained either by eosin to produce reddish colour (light to deep red) or as basophilic stain hematoxylin to stain blue colour (from light blue to deep blue) 
(Fig. 1). This staining clearly differentiates the presence of keratinised and nonkeratinized epithelium of oral origin in the enriched samples14. The eosinophilic cells with reddish colour were either from the keratinized origin such as stratum corneum or non-keratinized stratum superficial cells. Very  
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few stratum corneum cells were present. These cellswere confirmed by characteristics keratinization, and absence of nucleus and were also devoid of cytoplasmic inclusion bodies (Fig. 1).numerous stratum superficial cells of non
origin were observed with pyknotic nuclei. These cells were also devoid of any SARSinfection characteristics cytoplasmic inclusion body (Fig. 1). Another keratinised origin stratum granulosum cells with large nucleus along with characteristics oval shaped keratohyalin granules 
were observed with non-identifiable (SARSspecific or other type) inclusion bodies. Apart from these, there were many metabolically active basophilic (blue) oral epithelial cells such as stratum spinosum, and stratum intermedium in the sample. These cells showed the presence of 
SARS-CoV-2 specific inclusion body in the cytoplasm (black arrow) and also in the nucleus (white arrowhead) (Fig. 1). On careful 
 Fig. 1 — Cytology of enriched oral mucosal cells from the 
was performed in the cellular enriched (by cell strainer) bronchoalveolar secretion of ICU admitted and intubated COVID
identify different type of oral epithelium and possibility of presence of SARS
secretion contains stratum corneum (SC) stratum granulosum (SG), stratum superficial (SSF), stratum intermedium (SI), stratum
spinosum (SS) and very few cells of stratum basale (SB) cells. The probable SARS
inside the nucleus (white arrow heads) were indicated. The images were taken on Olympus microscope (Olympus BX53) using 
63X/100X objectives. The scale bar was given 
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1000X magnification, the viral infectioncharacteristics inclusion body were also seen in stratum superficial, stratum intermediate and striatum spinosum cells (Fig. 1).  
 Immuno-fluorescence imaging confirms the presence of 
SARS-CoV-2 virus on the various oral epithelium cellsThe bronchoalveolar secretion of intubated 
COVID-19 patient were analysed to identify the 
level of SARS-CoV-2 infection in different 
oral epithelium cells by confocal based 
immunofluorescence imaging using virus spike 
protein (S1) specific primary antibodies. It was found 
that the outermost layer of oral epithelium such as 
stratum corneum or stratum superficial were least 
infected or not at all infected by the SARS
virus (Fig. 2). However, the stratum intermedium and 
stratum spinosum cells were heavily infected in the 
severely infected COVID-19 patient (Fig. 2).
observed stratum corneum, granulosum, intermedium 
and  superficial  cells  in  one  frame
oropharyngeal and bronchoalveolar secretion using Pap staining. Pap staining 
-CoV-2 inclusion body. It was found that the enriched 
-CoV-2 inclusion body in cytoplasm (black arrow) and 
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 Fig. 2 — Confocal immunofluorescence microscopy of enriched oral epithelium from bronchoalveolar secretion of ICU admitted and 
intubated COVID-19 patients showing differential internalization of SARS
Immunofluorescence was performed using the virus spike protein (S1) specific antibody as primary antibody and Alexa
conjugated goat anti rabbit secondary antibody. SARS
keratinized origin and stratum intermedium of non
granulosum, stratum superficial cells and least or negligible in stratum corneum. It is a novel finding that virus was found mostly tow
the sub-basal lamina and least in the primarily exposed shedding surface of epithelium. Column (i) for nuclear stain by DAPI (
red fluorescence indicating the presence of SARS
The scale bar are given with each figure. The imaging was done either using 63X or 100X objective lens having DIC
corneum; SG: stratum granulosum; SSF: stratum superficial cells; SI: stratum intermedium; and N:Neutrophil
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-CoV-2 virus inside the different cells of oral epithelium. 
-CoV-2 virus showed prominent internalization in the stratum spinosum (SS) of 
-keratinised origin cells. The presence of virus was gradually decrease
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 level of infection of SARS-CoV-2 virus (Fig. 2, first 
image). Interestingly, the levels of infection were 
maximum in stratum spinosum and intermediate cells 
followed by stratum granulosum and stratum basale 
cells (Fig. 2).  
 
Scanning electron microscopic imaging reveals the presence of 
viruses on the surface of different oral epithelium cellsThe oral epithelium cells of bronchoalveolar 
secretion were imaged by scanning electron 
microscopes to identify the presence as well as level 
of SARS-CoV-2 virus infection on the surface of 
different types of oral epithelium cells. Very few 
stratum corneum cells were present with characteristic 
flat and keratinised structure. We did not find any 
alteration on the surface structure in comparison to 
literature reported in the stratum corneum cells as 
well as could not identify the presence of SARS
2 on the surface of these cells. However, small 
vesicles like structure, as a possible SARS
virus were seen in the stratum granulosum (small 
dotted shaped) and relatively less amount on the 
stratum superficial cells (Fig. 3). The relatively 
 






highest number of small dotted str
possibility of SARS-CoV-2 virus) were seen in the 
stratum intermedium and stratum spinosum cells 
(Fig. 3). It was found that the least or negligible 
viruses were present on the stratum corneum as well 
as on stratum superficial cells. T
intermedium cells have a relatively high number of 
viral presences on the surface (Fig. 3).
 
TEM provided the direct evidence of presence of SARS
virus on oral epithelium Para-keratinized and non-keratinised oral epithelial 
cells were clearly identified by the presence of 
conspicuous tono-fibrils and dispersed tonofilaments, 
respectively (Fig. 4). The transmission electron 
microscopic imaging of enriched oral epithelium from 
the oropharyngeal and bronchoalveolar secretion of 
intubated COVID-19 positive patients showed SARS
CoV-2 virus with prominent surface projections 
(spikes). The SARS-CoV-2 virus was not identified in 
the stratum corneum cells but some of the viruses 
were seen in the stratum superficial cells (Fig. 4).
Most of the stratum  granulosum
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 Fig. 3 — Scanning electron micrograph of oral epithelium from the oropharyngeal and bronchoalveolar secretion of COVID
intubated patients. Scanning electron microscopy were performed on the enriched oral epithelium cells from secretion after the critical 
point drying and sputter coating. Different oral epithelium cells from keratinised and non
size, shape and surface morphology. The magnified image of each type of epithelium cells with SARS
were reported using many patient samples. The SARS
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 Fig. 4 — Transmission electron microscopy of oral epithelium from oropharyngeal and bronchoalveolar secretion of COVID
intubated patients.The enriched squamous epithelium cells were embedded in epoxy resin, ultra
after staining with uranyl acetate and lead citrate. The keratinised and nonkeratinized cells were identified by presence of conspicuo
tonofilament (keratinised origin) and dispersed filament (non
non-keratinized origin) were identified by shape, size, granules, presence of cell organelles, nucleus size and shape. The presen
SARS-CoV-2 in these cells are denoted through the white arrow. It was found that most the SARS
stratum spinosum and stratum intermedium cells
 tono-fibrils (keratinised) showed the SARS
virus of size 110-205 nm in the vesicular body. 
However, these viruses, present near the nuclear 
membrane were relatively large in number and bigger 
size. Rounded shaped contrast dots in stratum 
spinosum, and stratum basale of keratinised origin 




-sectioned and imaged on Talos TEM 
-keratinized origin). The types of epitheliums in both origin (kera
-CoV-2 virus we
 
-CoV-2 were seen. The characteristics crown shape of the 
SARS-CoV-2 were prominently visible in the non
keratinised origin epithelium especially in the stratum 
intermedium and stratum spinosum (Fig. 4). The 
highest number of these viruses with well shapes 
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stratum spinosum cells. The stratum intermedium and 
stratum spinosum cells were heavily infected by the 
SARS-CoV-2 virus. Very few SARS-CoV-2 viruses 
were present in the stratum basale cells (Fig. 4). 
 
Discussion The novel severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) is an enveloped single 
stranded positive-sense RNA virus of size 50-200 nm 
(in vivo) with specific crown appearance due to 
presence of spikes protein. This virus is a causal agent 
of pandemic COVID-19 that primarily infected  
and internalized by interacting with angiotensin-
converting enzyme 2 (ACE-2) receptors of host cells 
through its spike protein (S protein) as a targeted cell 
internalization5. The host cell proteases TMPRSS2 
(transmembrane protease serine 2) cleaved the viral 
spike protein and released the spike fusion peptide 
that facilitates the virus internalization to the host 
cell9,10. The ACE-2, transmembrane protease serine 2 
(TMPRSS-2), and furin are the key components that 
assists the viral internalization and establishment of 
infection into the host cells5,9-11. ACE-2, TMPRSS-2, 
and furin mRNA expression was observed in  
taste bud-derived cultured cells, which was further 
confirmed by immunofluorescence5. ACE-2 and 
TMPRSS-2 protein expression were reported in 
various human tissues such as epithelial cells of the 
lung, intestine, kidney, oral mucosa and colon5,12-15. 
Among these tissues, the expression of these receptors 
on oral mucosa cells was higher in the metabolically 
active epithelial cells such as stratum spinosum or 
basale cells5,16. ACE-2 receptor was reported in the 
tongue tissues, oral mucosa, exfoliated epithelial cells 
in the saliva5. Single-cell RNA sequencing data of 
severely infected patients also reported to confirm the 
presence of SARS-CoV-2 in oral epithelium 
especially in supra-basal cells of the mucosae2. The 
probability of infection and replication of SARS-
CoV-2 virus on oral mucosa is critical to understand 
the underappreciated role in transmitting this virus.  
The oral cavity are lined by two types of 
specialized stratified squamous mucosa such as 
keratinized (attached gingiva and hard palate) and the 
non-keratinized (oral, labial, ventral tongue, 
oropharyngeal, and unattached gingiva) mucosae17. 
Due to presence of different kinds of epithelial cells in 
oropharyngeal secretions, it is challenging to 
understand the role of these oral cavity specific cells 
in infectivity, transmission and multiplication of 
COVID-19 virus using the molecular techniques. 
Though the role of ACE-2 and TMPRSS-2 are 
reported, there is no direct evidence of the level of 
infectivity and presence of these viruses in different 
kinds of oral mucosal cells. For the comprehensive 
descriptions of viral infection and to predict the 
vulnerabilities across the oral cavity, we have 
performed a series of microscopic imaging using  
imaging (for identification of cell types and  
inclusion bodies formed due to virus infection), 
immunofluorescence imaging (for direct identification 
of SARS-CoV-2 infection), scanning electron 
microscope (SEM) (for identifying the viruses on the 
surface of epithelial cells), and transmission electron 
microscope after ultra-sectioning of resin block  
for direct visualization of SARS-CoV-2 virus and its 
level of infectivity).  
Light microscopy cannot be directly used for viral 
identification purposes, but the presence of viral 
infection can be identified by different morphological 
features observed on the specific infected cells. Pap 
staining of cells were reported to reveal the viral 
presence by identifying some morphological features 
such as intracytoplasmic and intranuclear cytopathic 
inclusion18, distinct vacuolisation in the cytoplasm 
and multinucleation19. We have also found the 
presence of intracytoplasmic and intranuclear 
inclusion bodies in the cytoplasm and nucleus of 
different oral squamous epithelial cells (Fig. 1). This 
presence of inclusion body might be due to the viral 
infection, although we cannot differentiate between 
various viral infections (adenovirus, influenza, para 
influenza, herpes simplex virus, respiratory syncytial 
virus, cytomegalovirus, and measles). Hence, already 
confirmed SARS-CoV-2 positive patient’s cells 
containing inclusion bodies can be a sign of infection 
in those cells (Fig. 2).  
It was already shown by immunohistochemical 
analyses that ACE-2 was differentially expressed in 
the different oral epithelium from basal part  
to sub basal and shedding outermost area8. 
Immunohistochemistry based analysis of keratinised 
squamous epithelium confirms the presence of ACE-2 
expression in the nuclei and cytoplasm of the 
spinosum and basal cell layers. However, in the horny 
layer, the signal was absent in the nucleus as well as 
cytoplasm and the cell membrane20. These reports 
proved that ACE-2 and TMPRSS-2 were highly 
expressed in the sub basal region in comparison to 
basal and superficial shedding region of oral 




epithelium by in situ hybridisation (ISH)20. However, 
the presence of differential SARS-CoV-2 virus in 
stratum granulosum, stratum intermedium and stratum 
spinosum and stratum corneum were not explored. 
These oral epithelia are also one of the first cells that 
are encountered by SARS-CoV-2 virus. It is already 
known that the supra-basal cells of oral mucosa were 
continuously shed into saliva multiples times per day, 
so the expression patterning of supra-basal mucosal 
cells raised the possibility that sloughed cells may be 
infected and serve as a viral carrier to other parts of 
the body or to other humans2. Surprisingly, in our 
finding, based on immunofluorescence imaging, the 
infection level of SARS-CoV-2 was highest in sub 
basal epithelial cells and these findings correlated 
well with the higher expression level of ACE2 
and TMPRSS-2 (Figs. 1 & 2). Viral antigens were 
detected by immunofluorescence in different kinds of 
oral epithelial cells in the severely infected patients 
(Figs. 1 & 2). The high viral loads in the non-
keratinized oral epithelium of intubated patients 
support the potential for persons infected with SARS-
CoV-2 to readily transmit the virus, with prolonged 
and continued viral shedding in severe cases.  
The identification of presence of SARS-CoV-2 on 
the surface of the different oral mucosal cells are 
important to understand the infectivity and spread of 
the SARS-CoV-2 virus. It is obvious that these 
viruses would be present on the surface of  
oral mucosal cells from oropharyngeal and 
bronchoalveolar secretion of severally infected ICU 
admitted patients with ARDS (acute respiratory 
distress syndrome). These viruses were generated in 
large amounts in the alveolar sac of severally infected 
patients and can be adsorbed on the surface (simple 
adsorption) as well as internalise or multiply in the 
cytoplasm (infection and multiplication) of oral 
mucosal cells. There are many reports of SARS-CoV-2 
infected cultured cells and in the nasopharyngeal 
swab for the internalization and multiplication21,22. 
However, the presence of SARS-CoV-2 virus in the 
seriously infected patients with respect to various oral 
epithelium was not reported. In our SEM study, we 
have shown the presence of SARS-CoV-2 virus on 
the surface of different oral squamous epithelium. 
Very few SARS-CoV-2 viruses were present on the 
surface of the stratum corneum. These viruses may be 
adhered to the cell membrane by simple adsorption 
(because of high multiplication in critical condition) 
and were washed during the multiple washing  
steps involved in the sample preparation in 
immunofluorescence. This may be the reason that 
these viruses could not be detected in the 
immunofluorescence imaging on stratum corneum but 
detected in very low number in SEM (Fig. 2 & 3).The 
presence of SARS-CoV-2 viruses are least in stratum 
corneum, and gradually increased from stratum 
superficial, stratum basale, stratum granulosum to 
stratum intermedium cells and highest in the stratum 
spinosum cells (Fig. 3). This finding confirms the 
differential infection, multiplication and release of 
viruses through oral epithelium. The differential 
presence of ACE-2 receptors on these cells correlated 
with these finding2,5.  
TEM examination of oral epithelium cells from 
bronchoalveolar secretions showed virions with 
prominent surface projections (spikes) characteristic 
of the family Coronaviridae. Transmission electron 
microscopy finding also corroborated with the 
abundance of ACE-2 markers detected on the 
different oral mucosal cells2, 5 as well as confirmed by 
our study of immunofluorescence imaging (Figs. 2, 3 
& 4). SARS-CoV-2 virion particles are spherical in 
shape having coronal fibrils on the outer surface23 and 
electron dense material inside the particle24. Virion 
were visible in the membrane bound vesicles inside 
the cytoplasm and also freely in the cytoplasm  
(Fig. 4). The viruses were not detected in the stratum 
corneum cells of keratinoid origin as these cells are 
devoid of cellular machinery that helps in the 
internalisation of SARS-CoV-2 virus2,5. However, the 
outermost shedding area cells of non-keratinized 
origin with characteristic dispersed tono-filaments 
showed the presence of SARS-CoV-2 viruses on the 
cytoplasm.These viruses may be carried over from the 
pre-infected SARS-CoV-2 virus on sub basal cells of 
non-keratinised origin during shedding process. This 
is because the sub basal cells such as stratum 
intermedium or stratum spinosum were heavily 
infected from the crown like SARS-CoV-2 virus. This 
higher infection in these cells corroborates with the 
overexpression of ACE-2 and TMPRSS-2receptors.  
 
Conclusion This report describes the specific cellular and 
extracellular localization of SARS-CoV-2 in different 
oral epithelium cells, with Pap, immune-fluorescence, 
SEM, and TEM imaging. Together, these findings 
provide insight into SARS-CoV-2 pathogenesis, 
infectivity, and multiplication in the oral epithelium. 




The ultra-structural observations are consistent with 
molecular biology for SARS-CoV-2 infection.  
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